JKN24011

· Joincare Pharmaceutical Group Industry Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JKN24011, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial of JKN24011 in COPD [Phase 2]